EUVIMEDEUVIMED entdecken
Crossref

Licochalcone A in Folic Acid‐targeted Nanoparticles for Precise Anticancer Effects in Breast Cancer

Hongmei Zhang iD, Baiji Cui, Libo Wang, Hao Wu, Tianyi Zhang, Xianmin Feng iD, Yalin Dong

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202403342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Hongmei Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P. R. China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms, Chalcones, Folic Acid. Die Arbeit nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Based on the high expression of folic acid (FA) receptors in triple‐negative breast cancer cells, we encapsulated licochalcone A (LCA) in FA‐modified polyethylene glycol‐poly(lactic‐co‐glycolic) acid nanoparticles (NPs) for enhanced targeting and antitumor activity. In vitro experiments on 4T1 cells showed that NPs with FA modification exhibited excellent performance, including inhibition of cell proliferation, reduction of 50% inhibitory concentration values of LCA, and activation of reactive oxygen species production, thereby inhibiting cell proliferation. This drug delivery system promotes drug uptake by tumor cells and significantly improves drug delivery efficiency. Regarding relevant in vivo experiments in tumor‐bearing mice, we further demonstrated that NPs with FA modification have significant tumor‐targeting effects, as shown by drug penetration and small animal imaging experiments. Target‐modified NPs loaded with LCA significantly inhibited tumor growth and prolonged survival in mice. Histological analysis further demonstrated the positive effect of the preparation in reducing lung and liver metastasis lesions. Our study highlights that FA‐modified NPs can effectively deliver LCA to the tumor site, enhancing the potential application of LCA to inhibit tumor proliferation and metastasis, and providing new strategies and possibilities for treating triple‐negative breast cancer.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsBreast NeoplasmsChalconesFolic AcidNanoparticlesAnimalsFemaleHumansMiceCell Line, TumorCell ProliferationCell SurvivalDose-Response Relationship, DrugDrug CarriersDrug Screening Assays, AntitumorMice, Inbred BALB CParticle SizeReactive Oxygen SpeciesPolyethylene Glycols

Stichwörter der Autor:innen

Licochalcone Abreast cancerfolic acidnanoparticles

Substanzen

Antineoplastic AgentsChalconesDrug CarriersFolic Acidlicochalcone AReactive Oxygen SpeciesPolyethylene Glycols

Autor:innen und Institutionen

  • Department of Pharmacy, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, P. R. China.
  • School of Pharmacy, Jilin Medical University, Jilin, P. R. China.
  • Department of Pathology, Jilin People's Hospital, Jilin, P. R. China.
  • School of Basic Medicine Sciences, Jilin Medical University, Jilin, P. R. China.

ORCID-Profile: Hongmei Zhang, Xianmin Feng

Zitieren

APA

Zhang, H., Cui, B., Wang, L., Wu, H., Zhang, T., Feng, X., & Dong, Y. (2025). Licochalcone A in Folic Acid‐targeted Nanoparticles for Precise Anticancer Effects in Breast Cancer. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202403342

Vancouver

Zhang H, Cui B, Wang L, Wu H, Zhang T, Feng X, et al. Licochalcone A in Folic Acid‐targeted Nanoparticles for Precise Anticancer Effects in Breast Cancer. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202403342

BibTeX
@article{Zhang2025,
  author = {Zhang, Hongmei and Cui, Baiji and Wang, Libo and Wu, Hao and Zhang, Tianyi and Feng, Xianmin and Dong, Yalin},
  title = {Licochalcone A in Folic Acid‐targeted Nanoparticles for Precise Anticancer Effects in Breast Cancer},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202403342}
}
Kostenlos starten →